← 治験一覧に戻る
麻酔薬と肝切除手術後の急性腎障害
基本情報
- NCT ID
- NCT02174575
- ステータス
- 取り下げ
- 試験のフェーズ
- 第4相
- 試験タイプ
- 介入
- 目標被験者数
- 0
- 治験依頼者名
- Tokyo Medical and Dental University
概要
* It has been shown that patients who undergo liver resection surgery are at high risk for postoperative acute kidney injury (AKI). * Sevoflurane may increase the risk for postoperative AKI because of production of compound-A. * Therefore, we have planned to investigate the effects of different anesthetic agents on postoperative renal function. * Patients undergoing liver resection surgery are randomized into 2 groups. * One of the groups receives sevoflurane and the other group receives desflurane. * Blood and urine specimen are sampled both pre- and postoperatively, and several biomarkers are compared between the groups.
対象疾患
Hepatocellular CarcinomaHepatomaCholangiocarcinomaGallbladder Neoplasms
介入
Sevoflurane(DRUG)
Desflurane(DRUG)
依頼者(Sponsor)
実施施設 (1)
東京科学大学病院
Tokyo, Japan